Compare Amcor PLC (AMCR) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amcor PLC vs Regeneron Pharmaceuticals Inc — how do they compare? Amcor PLC trades at $46.51 (market cap $21.92B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 3.7× Amcor PLC's market cap, and Amcor PLC pays the higher dividend (5.49%). Which is the better fit depends on your goals.
| AMCR | REGN | |
|---|---|---|
Market Cap | $21.92B | $82.06B |
Sector | Basic Materials | Health |
52-Week High | $50.58 | $812.27 |
52-Week Low | $36.69 | $555.51 |
Enterprise Value | $37.03B | $76.77B |
Dividend Yield | 5.49% | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amcor PLC
Amcor is a global plastics packaging behemoth, with global sales of USD 14.5 billion in fiscal 2022 following the acquisition of Bemis in 2019. Amcor's operations span over 40 countries globally and include significant emerging-market exposure equating to circa 20% of sales. Amcor's capabilities span flexible and rigid plastic packaging, which sell into defensive food, beverage, healthcare, household, and personal-care end markets.
Read more on AMCR →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
